compound 20 has been researched along with lisinopril in 2 studies
| Studies (compound 20) | Trials (compound 20) | Recent Studies (post-2010) (compound 20) | Studies (lisinopril) | Trials (lisinopril) | Recent Studies (post-2010) (lisinopril) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 2,210 | 648 | 491 |
| Protein | Taxonomy | compound 20 (IC50) | lisinopril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.0021 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.287 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, GR; Waller, CL | 1 |
| Chibale, K; Nchinda, AT; Redelinghuys, P; Sturrock, ED | 1 |
2 other study(ies) available for compound 20 and lisinopril
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and com
Topics: Angiotensin-Converting Enzyme Inhibitors; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thermolysin | 1993 |
Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Molecular Structure; Peptidyl-Dipeptidase A; Structure-Activity Relationship | 2006 |